UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PTCT — Ptc Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in PTCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,649,985
-$1,368,603 QoQ
Shares Held
126,963
-3.7% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 41.043453604593466.ToString("F0")%
Shared 0.ToString("F0")%
None 58.95654639540654.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. PTCT ranks #45 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,649,985 | 126,963 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,018,588 | 131,893 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,971,837 | 129,898 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,217,176 | 229,672 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,109,350 | 178,755 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $7,233,727 | 160,251 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,970,545 | 133,977 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,660,449 | 152,402 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,300,929 | 79,097 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,179,910 | 79,097 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,697,017 | 75,726 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,988,836 | 73,490 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,559,854 | 73,490 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,590,558 | 67,869 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,150,843 | 261,969 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,066,772 | 276,255 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,431,452 | 467,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,126,921 | 480,214 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,760,702 | 477,310 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,461,106 | 460,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,972,161 | 316,202 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $27,105,982 | 444,142 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $19,982,818 | 427,440 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $24,953,016 | 491,782 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,420,313 | 368,086 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||